A Study of TAK-625 for the Treatment of Alagille Syndrome (ALGS)
Not yet recruiting
Takeda
Phase 3
2022-09-27
The main aim of the study is to check if TAK-625 improves symptoms of Alagille Syndrome
(ALGS), side effect from the study treatment or TAK-625, and how much TAK-625 stays in their
blood over time. This will help the study sponsor (Takeda) to work out the best dose to give
people in the future.
The participants will be treated with TAK-625 for up to the end of study (about 34 months).
Participants will visit their study clinic 9 times from the start of study. After 9 times
visits, participants will visit their study clinic every 12 weeks up to the end of study.
A Study of TAK-625 for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC)
Not yet recruiting
Takeda
Phase 3
2022-09-16
The main aim of the study is to check if TAK-625 improves symptoms of Progressive Familial
Intrahepatic Cholestasis (PFIC), side effect from the study treatment or TAK-625, and how
much TAK-625 stays in their blood over time. This will help the study sponsor (Takeda) to
work out the best dose to give people in the future.
The participants will be treated with TAK-625 for up to the end of study (about 34 months).
Participants will visit their study clinic 15 times from the start of study. After 15 times
visits, participants will visit their study clinic every 12 weeks up to the end of study.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
